FOUNDATION MEDICINE INC (FMI) Stock Price & Overview

NASDAQ:FMIUS3504651007

Current stock price

137
+0.2 (+0.15%)
At close:
136.95
-0.05 (-0.04%)
Pre-Market:

The current stock price of FMI is 137 null. Today FMI is up by 0.15%. In the past month the price increased by 0.22%. In the past year, price increased by 262.91%.

FMI Key Statistics

52-Week Range35.105 - 137.2
Current FMI stock price positioned within its 52-week range.
1-Month Range136.55 - 137
Current FMI stock price positioned within its 1-month range.
Market Cap
5.088B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-4.21
Dividend Yield
N/A

FMI Stock Performance

Today
+0.15%
1 Week
+0.15%
1 Month
+0.22%
3 Months
+93.37%
Longer-term
6 Months +102.07%
1 Year +262.91%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

FMI Stock Chart

FOUNDATION MEDICINE INC / FMI Daily stock chart

FMI Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to FMI. When comparing the yearly performance of all stocks, FMI is one of the better performing stocks in the market, outperforming 99.15% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

FMI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to FMI. While FMI seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FMI Earnings

Next Earnings DateN/A
Last Earnings DateN/A

FMI Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y2%
Revenue Next YearN/A

FMI Financial Highlights

Over the last trailing twelve months FMI reported a non-GAAP Earnings per Share(EPS) of -4.21. The EPS decreased by -38.46% compared to the year before.


Income Statements
Revenue(TTM)201.42M
Net Income(TTM)-141.55M
Industry RankSector Rank
PM (TTM) -70.28%
ROA -73.17%
ROE 1658.26%
Debt/Equity -12.89
Chartmill High Growth Momentum
EPS Q2Q%22.14%
Sales Q2Q%62.86%
EPS 1Y (TTM)-38.46%
Revenue 1Y (TTM)68.43%

FMI Ownership

Ownership
Inst Owners33.17%
Shares37.14M
Float36.03M
Ins Owners106.69%
Short Float %N/A
Short RatioN/A

About FMI

Company Profile

Foundation Medicine, Inc. provides molecular information products primarily in the United States. The company offers FoundationOne(TM) a molecular information product for the analysis of routine cancer specimens in a clinical setting. Its molecular information platform generates actionable genomic information about a patient's individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. Foundation Medicine, Inc. is based in Cambridge, Massachusetts.

Company Info

FOUNDATION MEDICINE INC

150 Second Street

Cambridge MA 02141

CEO: Troy Cox

Phone: 617-418-2200

FOUNDATION MEDICINE INC / FMI FAQ

Can you describe the business of FOUNDATION MEDICINE INC?

Foundation Medicine, Inc. provides molecular information products primarily in the United States. The company offers FoundationOne(TM) a molecular information product for the analysis of routine cancer specimens in a clinical setting. Its molecular information platform generates actionable genomic information about a patient's individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. Foundation Medicine, Inc. is based in Cambridge, Massachusetts.


Can you provide the latest stock price for FOUNDATION MEDICINE INC?

The current stock price of FMI is 137 null. The price increased by 0.15% in the last trading session.


What is the dividend status of FOUNDATION MEDICINE INC?

FMI does not pay a dividend.


What is the ChartMill technical and fundamental rating of FMI stock?

FMI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.